Search Results

SCH 58261 25 mg  | 99.75%

TargetMol

SCH 58261 is a potent and selective A2a adenosine receptor antagonist.The Ki =2.3 nM for rat A2a and 2 nM is for bovine A2a.

More Information Supplier Page

SCH772984 5 mg  | 98.01%

TargetMol

SCH 772984 is a potent inhibitor of ERK1/ERK2 (IC50: 4/1 nM) and has only weak inhibitory for other 300 tested kinases.

More Information Supplier Page

SCH772984 50 mg  | 98.01%

TargetMol

SCH 772984 is a potent inhibitor of ERK1/ERK2 (IC50: 4/1 nM) and has only weak inhibitory for other 300 tested kinases.

More Information Supplier Page

SCH772984 2 mg  | 98.01%

TargetMol

SCH 772984 is a potent inhibitor of ERK1/ERK2 (IC50: 4/1 nM) and has only weak inhibitory for other 300 tested kinases.

More Information Supplier Page

SCH772984 25 mg  | 98.01%

TargetMol

SCH 772984 is a potent inhibitor of ERK1/ERK2 (IC50: 4/1 nM) and has only weak inhibitory for other 300 tested kinases.

More Information Supplier Page

SCH772984 10 mg  | 98.01%

TargetMol

SCH 772984 is a potent inhibitor of ERK1/ERK2 (IC50: 4/1 nM) and has only weak inhibitory for other 300 tested kinases.

More Information Supplier Page

Tenofovir alafenamide 5 mg  | 99.00%

TargetMol

Tenofovir Alafenamide (GS-7340) is a nucleotide reverse transcriptase inhibitor (NRTI) and a novel ester prodrug of the antiretroviral tenofovir.

More Information Supplier Page

Mocetinostat 100 mg  | 99.37%

TargetMol

Mocetinostat is an orally available HDAC inhibitor with most potency for HDAC1 (IC50: 0.15 μM), 2- to 10- fold selectivity against HDAC2/3/11.

More Information Supplier Page

AZD4547 200 mg  | 99.56%

TargetMol

AZD4547, a new-type specific FGFR inhibitor, targets for FGFR1/2/3 (IC50: 0.2/2.5/1.8 nM in cell-free assays).

More Information Supplier Page